journal article·2021-01Open access

Progress and perspective of microneedle system for anti-cancer drug delivery

Dongdong Li, Doudou Hu, Hongxia Xu, Hirak K. Patra, Xiangrui Liu, Zhuxian Zhou, Jianbin Tang, Nigel Slater, Youqing Shen

Biomaterials· Volume 264

Abstract

Transdermal drug delivery exhibited encouraging prospects, especially through superficial drug administration routes. However, only a few limited lipophilic drug molecules could cross the skin barrier, those are with low molecular weight and rational Log P value. Microneedles (MNs) can overcome these limitations to deliver numerous drugs into the dermal layer by piercing the outermost skin layer of the body. In the case of superficial cancer treatments, topical drug administration faces severely low transfer efficiency, and systemic treatments are always associated with side effects and premature drug degradation. MN-based systems have achieved excellent technical capabilities and been tested for pre-clinical chemotherapy, photothermal therapy, photodynamic therapy, and immunotherapy. In this review, we will focus on the features, progress, and opportunities of MNs in the anticancer drug delivery system. Then, we will discuss the strategies and advantages in these works and summarize challenges, perspectives, and translational potential for future applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Toxin Mechanisms and Immunotoxins

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Schaefer · 2013
2. A predictive algorithm for skin permeability - the effects of molecular-size and hydrogen-bond activity10.1023/A:1016236932339 ↗
3. Transdermal drug delivery10.1038/nbt.1504 ↗
4. Transdermal delivery of drugs with microneedles-potential and challenges10.3390/pharmaceutics7030090 ↗
5. Polymeric microneedles for transdermal protein delivery10.1016/j.addr.2018.01.015 ↗
6. Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development10.1016/j.mser.2016.03.001 ↗
7. The cost of unsafe injections
8. Donnelly · 2012
9. What is the 'true' function of skin?
10. Microneedle technologies for (trans)dermal drug and vaccine delivery10.1016/j.jconrel.2012.01.042 ↗
11. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?10.1002/jps.21817 ↗
12. Modeling the human skin barrier - towards a better understanding of dermal absorption10.1016/j.addr.2012.04.003 ↗
13. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
14. Microneedles: a new frontier in nanomedicine delivery10.1007/s11095-016-1885-5 ↗
15. Breaching the skin's barrier to drugs10.1038/nbt0204-165 ↗
16. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues10.1016/j.jconrel.2017.11.048 ↗
17. Design principles of chemical penetration enhancers for transdermal drug delivery10.1073/pnas.0501176102 ↗
18. Use of iontophoresis for the treatment of cancer10.1016/j.jconrel.2018.06.020 ↗
19. Ultrasound mediated transdermal drug delivery10.1016/j.addr.2014.01.007 ↗
20. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement10.1016/j.addr.2018.02.003 ↗
21. Current advancements in transdermal biosensing and targeted drug delivery10.3390/s19051028 ↗
22. Device-assisted transdermal drug delivery10.1016/j.addr.2017.08.009 ↗
23. Current advances in the fabrication of microneedles for transdermal delivery10.1016/j.jconrel.2014.04.052 ↗
24. Microneedles and transdermal applications10.1517/17425247.4.1.19 ↗
25. The role of microneedles for drug and vaccine delivery10.1517/17425247.2014.938635 ↗
26. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique10.1007/s11095-010-0169-8 ↗
27. Recent advances of controlled drug delivery using microfluidic platforms10.1016/j.addr.2017.09.013 ↗
28. Hydrogel-forming microneedle arrays can Be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet10.1007/s11095-014-1301-y ↗
29. Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected10.1002/jps.23921 ↗
30. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo10.1016/j.ejpb.2017.04.029 ↗
31. Delivery of methotrexate and characterization of skin treated by fabricated PLGA microneedles and fractional ablative laser10.1007/s11095-018-2369-6 ↗
32. Polymer microneedles fabricated from PCL and PCL/PEG blends for transdermal delivery of hydrophilic compounds10.1016/j.jtice.2015.01.003 ↗
33. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs10.1016/j.jconrel.2014.02.007 ↗
34. Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug10.1002/jps.24159 ↗
35. Microprecision delivery of oligonucleotides in a 3D tissue model and its characterization using optical imaging10.1021/mp300717f ↗
36. In vivo iontophoretic delivery of salmon calcitonin across microporated skin10.1002/jps.23222 ↗
37. Delivery of salmon calcitonin using a microneedle patch10.1016/j.ijpharm.2011.11.046 ↗
38. Hydrogels based on PLGA-PEG-PLGA triblock co-polymers as sustained release reservoirs for the delivery of pDNA to microneedle treated human skin
39. Microneedle facilitated cutaneous delivery of a non-viral gene complex to the viable epidermis
40. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques10.1002/jps.21981 ↗
41. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles10.1016/j.ijpharm.2008.10.008 ↗
42. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery10.1007/s11095-011-0419-4 ↗
43. Sodium hyaluronate/chitosan composite microneedles as a single-dose intradermal immunization system10.1021/acs.biomac.8b00441 ↗
44. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design10.1016/j.actbio.2017.11.004 ↗
45. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination10.1016/j.biomaterials.2012.12.041 ↗
46. Microarray patches: potentially useful delivery systems for long-acting nanosuspensions10.1016/j.drudis.2017.10.013 ↗
47. Novel bilayer dissolving microneedle arrays with concentrated PLGA nanomicroparticles for targeted intradermal delivery: proof of concept10.1016/j.jconrel.2017.10.005 ↗
48. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles10.1016/j.jconrel.2017.04.022 ↗
49. Microneedle mediated delivery of nanoparticles into human skin10.1016/j.ijpharm.2008.08.040 ↗
50. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye10.1111/j.2042-7158.2012.01557.x ↗
51. Immunogenicity of diphtheria toxoid and poly(I:C) loaded cationic liposomes after hollow microneedle-mediated intradermal injection in mice10.1016/j.ijpharm.2018.06.001 ↗
52. Microneedles in the clinic10.1016/j.jconrel.2017.05.029 ↗
53. Minimally invasive microneedles for ocular drug delivery10.1080/17425247.2016.1218460 ↗
54. Microneedle-based device for the one-step painless collection of capillary blood samples10.1038/s41551-018-0194-1 ↗
55. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery10.1038/nm0402-415 ↗
56. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery10.1021/nn302639r ↗
57. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization10.1073/pnas.0908842106 ↗
58. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)
59. Dissolving microneedle arrays for transdermal delivery of amphiphilic vaccines10.1002/smll.201700164 ↗
60. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery10.1007/s10544-007-9133-8 ↗
61. Mechanism of fluid infusion during microneedle insertion and retraction10.1016/j.jconrel.2006.02.017 ↗
62. Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors10.1111/php.12209 ↗
63. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery10.1002/adfm.201200864 ↗
64. Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?10.3389/fphar.2018.00245 ↗
65. Adding nanotechnology to the metastasis treatment arsenal10.1016/j.tips.2019.04.002 ↗
66. Combination of microneedles and microemulsions to increase celecoxib topical delivery for potential application in chemoprevention of breast cancer10.1016/j.ijpharm.2019.02.011 ↗
67. Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model10.1016/j.ijpharm.2018.12.022 ↗
68. Derma roller (R) microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect10.1016/j.msec.2019.02.095 ↗
69. Enhancement in the transdermal and localized delivery of honokiol through breast tissue10.1208/s12249-018-1158-1 ↗
70. Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy10.1021/acsami.8b12926 ↗
71. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer10.1080/10717544.2018.1455760 ↗
72. Novel in situ forming hydrogel microneedles for transdermal drug delivery10.1007/s13346-016-0328-5 ↗
73. Poly (vinyl alcohol) microneedles: fabrication, characterization, and application for transdermal drug delivery of doxorubicin10.1016/j.ejpb.2018.05.017 ↗
74. Qualitative and quantitative analysis of lateral diffusion of drugs in human skin10.1016/j.ijpharm.2018.04.013 ↗
75. Enhanced skin delivery of vismodegib by microneedle treatment10.1007/s13346-015-0241-3 ↗
76. Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system10.1016/j.ijpharm.2012.10.042 ↗
77. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans10.1016/j.jconrel.2013.06.008 ↗
78. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitro evaluation10.1007/s10544-015-9944-y ↗
79. Influence of salivary washout on drug delivery to the oral cavity using coated microneedles: an in vitro evaluation10.1016/j.ejps.2016.08.023 ↗
80. Drug-delivery system based on salmon DNA nano- and micro-scale structures
81. Microstereolithography and characterization of poly(propylene fumarate)-based drug-loaded microneedle arrays10.1088/1758-5090/7/4/045001 ↗
82. A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug10.1007/s10544-015-9967-4 ↗
83. Cooperative nanomaterial system to sensitize, target, and treat tumors10.1073/pnas.0909565107 ↗
84. Photodynamic therapy with endogenous protoporphyrin .9. Basic principles and present clinical-experience10.1016/1011-1344(90)85083-9 ↗
85. Intradermal delivery of a near-infrared photosensitizer using dissolving microneedle arrays10.1016/j.xphs.2018.05.017 ↗
86. Microneedle-Assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma10.1021/acsnano.8b03007 ↗
87. Novel approach of using near-infrared responsive PEGylated gold nanorod coated poly(L-lactide) microneedles to enhance the antitumor efficiency of docetaxel-loaded MPEG-PDLLA micelles for treating an A431 tumor10.1021/acsami.7b03604 ↗
88. Doxorubicin/gold nanoparticles coated with liposomes for chemo-photothermal synergetic antitumor therapy10.1088/1361-6528/aad358 ↗
89. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
90. Near-infrared light-responsive composite microneedles for on-demand transdermal drug delivery10.1021/acs.biomac.5b00185 ↗
91. LaB6 nanoparticles with carbon-doped silica coating for fluorescence imaging and near-IR photothermal therapy of cancer cells10.1016/j.actbio.2013.03.034 ↗
92. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy10.1021/acsnano.5b05043 ↗
93. On/off-switchable anti-neoplastic nanoarchitecture
94. Au nanocage-strengthened dissolving microneedles for chemo-photothermal combined therapy of superficial skin tumors10.1021/acsami.7b18293 ↗
95. Composite-dissolving microneedle patches for chemotherapy and photothermal therapy in superficial tumor treatment10.1039/C8BM00005K ↗
96. Potential of microneedles in enhancing delivery of photosensitising agents for photodynamic therapy10.1016/j.pdpdt.2014.09.003 ↗
97. Microneedle-mediated intradermal nanoparticle delivery: potential for enhanced local administration of hydrophobic pre-formed photosensitisers10.1016/j.pdpdt.2010.09.001 ↗
98. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy10.1016/j.jconrel.2008.05.002 ↗
99. Microfabricated microneedles: a novel strategy for enhancing topical delivery of 5-aminolevulinic acid and preformed photosensitisers
100. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer10.1111/j.1751-1097.2008.00417.x ↗